Abstract B039: T-cell–dominated interferon signaling drives immune checkpoint inhibitor–associated pneumonitis and reveals actionable cytokine targets
Paytsar Topchyan(APLA Health), Alexandra Drakaki(APLA Health), Gregory A. Fishbein(University of California, Los Angeles), Willy Hugo(University of California, Los Angeles), Dimitrios Stefanoudakis(APLA Health), Nikhita Kathuria‐Prakash(University of California, Los Angeles), Leland Damron(APLA Health), Melissa G . Lechner(APLA Health), Richard Watson(APLA Health), Min Zhang(APLA Health), Jarod Olay(APLA Health)
Cited by 0
Related Papers
MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells
|Oncogene|2011|162
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
|Current Issues in Molecular Biology|2024|78